Skip to content

Growth Hormones and Cells in Human Milk Depending on Gestational Age

Growth Hormones and Cells in Human Milk Depending on Gestational Age and Lactation Phase

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02662517
Acronym
BMProfile
Enrollment
43
Registered
2016-01-25
Start date
2016-03-01
Completion date
2017-01-01
Last updated
2020-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lactation

Keywords

Neurotrophins, Stem Cells, Prematurity

Brief summary

Human breast milk contains growth factors including neurotrophins and cells with neuroprotective potential. Concerning growth factors milk of preterms differs significantly from term milk. The aim of this study is to give a profile of human milk concerning non-nutritive factors depending on gestational age and lactation phase.

Detailed description

Neurotrophins (epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), nerve growth factor (NGF), brain derived neurotrophic factor (BDNF)) as well as amount of cells, especially positive for sex-determining transformer protein (TRA)-1-81 and stage-specific embryonic antigen (SSEA)-4, are planned to be quantified in human breast milk of extremely preterm newborns as well as term newborns at different stages of lactation.

Interventions

None listed

Sponsors

University Hospital of Cologne
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* the newborn infant is being fed with own mothers milk

Exclusion criteria

* low amount of breast milk

Design outcomes

Primary

MeasureTime frameDescription
neurotrophins compositionday 7Concentration of Neurotrophins EGF, VEGF, NGF, BDNF in the human milk

Secondary

MeasureTime frameDescription
Amount of cells positive for surface markers TRA-1-81 and SSEA-4day 7surface markers characteristic for pluripotent stem cells

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026